morantel has been researched along with Weight-Gain* in 6 studies
1 trial(s) available for morantel and Weight-Gain
Article | Year |
---|---|
Efficacy of morantel sustained release trilaminate bolus against gastrointestinal nematodes in grazing dairy calves in Kenya.
The efficacy of morantel sustained release trilaminate (MSRT) bolus against gastrointestinal nematodes was evaluated under field conditions over a 10-month period. Twenty weaner calves were randomly divided into 2 groups of 10 calves each and grazed from March to December on adjacent, similarly contaminated paddocks. Group 1 calves (T-1) served as untreated controls while group 2 calves (T-2) were dosed at turnout with MSRT bolus designed to release morantel tartrate continuously for 90 days. The efficacy of MSRT was assessed by comparison of parasitological data (faecal worm egg counts, herbage larval counts, worm counts from tracer calves and set-stocked trial calves, determination of haematological parameters and pepsinogen levels), weight gains and clinical status of the animals. Faecal egg counts from the treated group (T-2) were reduced by 100% (P < 0.001) following treatment and remained significantly (P < 0.05) lower than counts from T-1 calves up to trial termination. The use of MSRT bolus resulted in a reduction of 92% (P < 0.001) in the number of gastrointestinal nematodes in set-stocked calves at the end of the study and a 55 to 85.7% reduction in herbage larval infectivity as reflected in lowered parasite burdens in tracer calves. At the trial termination, the control calves had gained on average (+/- s.d.) 59.4 +/- 4.8 kg (200.0 +/- 7.4 g day-1) and the treated ones on an average 128.6 +/- 10.5 kg (530.0 +/- 13.1 g day-1). Topics: Animals; Antinematodal Agents; Cattle; Cattle Diseases; Delayed-Action Preparations; Dose-Response Relationship, Drug; Fasciola; Fascioliasis; Feces; Female; Intestinal Diseases, Parasitic; Kenya; Morantel; Parasite Egg Count; Pepsinogens; Time Factors; Tropical Climate; Weight Gain | 1997 |
5 other study(ies) available for morantel and Weight-Gain
Article | Year |
---|---|
Prophylaxis of bovine trichostrongylidosis in the alpine region: effect of pasture contamination on infections in calves receiving a morantel sustained-release trilaminate bolus in mid-July.
In the alpine region, mixed grazing systems with cattle of different age, origin and prophylaxis against trichostrongylid infections are most common. Under these conditions the administration of anthelmintic devices to susceptible calves is frequently postponed to June or July to achieve a better protection during the period of increased pasture infectivity in summer and autumn. In a field experiment with 27 first-year grazing calves a morantel sustained-release trilaminate bolus (MSRT, Pfizer) was given to two groups (Groups A and B) of nine naturally infected calves each, on 22 July. Calves of Group B were moved to a clean pasture (B) 1 day later, whereas the calves of Group A remained on the previous pasture (A) together with nine untreated calves (Group C). The contamination with infective larvae (L3) on Pasture A remained below 1000 L3 kg-1 dry matter, which was sufficient to produce clinical parasitic gastroenteritis in five of nine control calves. The MSRT bolus reduced the mean egg output by more than 90% within 14 days after administration and prevented clinical parasitic gastroenteritis in the calves of Groups A and B. Owing to the persisting infection risk on Pasture A, the mean serum pepsinogen levels reached about 3000 mU tyrosine in the calves of Group A in September compared with approximately 2000 mU in Group B grazing the clean pasture. However, the differences in pasture contamination were not reflected in the mean bodyweight of the calves, which were 20 kg heavier at the end of the trial in both MSRT-treated groups compared with the control calves (P < 0.01). As there is a high probability that a moderate larval contamination is present on prealpine and alpine community pastures in summer, the metaphylactic use of an MSRT bolus in mid-July is likely to limit trichostrongylid infections within a subclinical range and thus provides sufficient protection of susceptible calves against parasitic gastroenteritis. Topics: Animals; Cattle; Cattle Diseases; Delayed-Action Preparations; Feces; Female; Intestinal Diseases, Parasitic; Male; Morantel; Parasite Egg Count; Pepsinogens; Seasons; Switzerland; Trichostrongyloidiasis; Weather; Weight Gain | 1994 |
Efficacy of the morantel sustained release trilaminate bolus against gastrointestinal nematodes and its influence on immunity in calves.
An experiment was conducted in calves to investigate the efficacy of a morantel sustained release trilaminate bolus (MSRT) to control gastrointestinal parasitism and to assess the development of immunity during the use of MSRT. Two groups (M and U) of four calves each were infected three times a week with a mixed Ostertagia ostertagi and Cooperia oncophora infection for 12 weeks. Calves of Group M received an MSRT at the start of the experiment. Twenty weeks after the start of the experiment, all animals, including a previously uninfected control group (C), received a challenge with 100,000 Ostertagia and 100,000 Cooperia. After a further 4 weeks all calves were necropsied for worm counts. During the trial calves were weighed and faecal egg counts, larval differentiation and pepsinogen concentrations were determined. The results demonstrated the high level of efficacy of the MSRT in reducing the faecal egg output and preventing parasitic gastroenteritis under conditions of a continuous high rate of infection. Efficacy of treatment was higher for Cooperia than for Ostertagia. Post-mortem worm counts suggested a partially impaired immunity build-up in Group M, at least for Cooperia. Topics: Animals; Cattle; Cattle Diseases; Delayed-Action Preparations; Feces; Immunity, Active; Intestinal Diseases, Parasitic; Morantel; Nematode Infections; Ostertagiasis; Parasite Egg Count; Pepsinogens; Random Allocation; Trichostrongyloidiasis; Weight Gain | 1992 |
Evaluation of the morantel sustained release trilaminate in the control of parasitic gastroenteritis in first season grazing cattle.
A novel intraruminal bolus developed for the sustained delivery of the anthelmintic morantel tartrate was evaluated in the seasonal control of parasitic gastroenteritis in first season grazing calves. The morantel sustained release trilaminate is a trilaminate sheet consisting of a central lamina of a morantel tartrate/ethylene vinyl acetate matrix coated on both sides with a thin impermeable layer of ethylene vinyl acetate. A symmetrical pattern of circular perforations punched through the device controls the release of morantel. Administration of the trilaminate to calves significantly reduced their faecal egg output compared with untreated controls and thus reduced pasture larval contamination. Clinical parasitic gastroenteritis was prevented in the treated calves and there were significant reductions in their worm burdens compared with the untreated control calves both during and at the end of the grazing season. The control of parasitic gastroenteritis resulted in a significantly greater (P less than 0.0001) weight gain, of 45 kg, by the treated calves. Topics: Animals; Cattle; Cattle Diseases; Delayed-Action Preparations; Feces; Gastroenteritis; Intestinal Diseases, Parasitic; Male; Morantel; Parasite Egg Count; Pyrimidines; Time Factors; Trichostrongyloidea; Trichostrongyloidiasis; Weight Gain | 1989 |
Efficacy of a novel sustained release anthelmintic device in preventing parasitic gastroenteritis in first-season calves.
The efficacy of the first of a new generation of intraruminal devices for cattle, the morantel sustained release trilaminate, was assessed in two field trials. In each trial the animals were divided into a control group and a treated group. The device was administered to each calf before turn out in the spring and the reduction of gastrointestinal parasitism resulted in a substantial reduction in the level of pasture contamination with infective helminth larvae later in the season. Compared with the control calves the treated calves had a 94 per cent reduction of worm burdens acquired over the entire grazing season in the first trial, despite the controls being treated for clinical disease in September. In the second trial four anthelmintic treatments were administered to the control calves during the grazing season, but nevertheless a 64 per cent reduction of worm burdens in the treated group compared to the control group was recorded. The control of parasitic infection by the sustained-release devices resulted in mean weight gain advantages of 28.3 kg and 34.7 kg by the treated animals in the first and second trials respectively. Topics: Animals; Cattle; Cattle Diseases; Delayed-Action Preparations; Female; Gastroenteritis; Intestinal Diseases, Parasitic; Male; Morantel; Parasite Egg Count; Pyrimidines; Weight Gain | 1989 |
Control of gastrointestinal parasitism with an oxfendazole pulse-release anthelmintic device.
The efficacy of a pulse-release oxfendazole bolus (OPRB) against gastrointestinal nematodes was evaluated under field conditions and compared with a sustained release morantel bolus (MSRB). Three groups of 10 calves were grazed from May to September on adjacent, similarly contaminated 3-acre paddocks. One group was dosed at turnout with the OPRB, the second group with the MSRB and the third group left as nontreated controls. Pasture larval counts peaked at greater than 60,000 larvae/kg dry weight of herbage in September on the control paddock, associated with a mean egg count of 1040 eggs/g faeces and clinical symptoms. A low rise in larval counts occurred on the MSRB plot, and also low helminth egg counts. On the OPRB plot, pasture larvae and faecal egg counts were recorded only intermittently; the September egg counts were only 3.5% of those of the controls; serum pepsinogen data showed a similar picture. At the end of the experiment, the OPRB calves had a mean weight advantage of 40 kg over the controls, and 12 kg over the MSRB group. Feed intakes were highest in the OPRB group in July and September. Topics: Animals; Benzimidazoles; Cattle; Cattle Diseases; Delayed-Action Preparations; Feces; Intestinal Diseases, Parasitic; Male; Morantel; Nematoda; Nematode Infections; Parasite Egg Count; Weight Gain | 1988 |